KEY TAKEAWAYS Credit: Tanmoy Saha, Brigham and Women’s Hospital KEY TAKEAWAYS Lu...
In a major breakthrough for lithium recovery technologies, researchers from the ...
National University of Singapore (NUS) chemists have developed hexavalent photoc...
In August 2021, an earthquake struck southwest Haiti, killing thousands of peopl...
BIRMINGHAM, Ala. – Memory immune cells reside in many tissues, poised to react t...
The sweet smell of strawberries and other fruits is thanks to a chemical compoun...
A panel of experts advising the Food and Drug Administration announced earlier t...
Initially thought of as a potential game-changer for metabolic-associated steato...
Phase 3 trial results for Loqtorzi (toripalimab) and Avastin (bevacizumab) show ...
Pfizer’s gene therapy for Duchenne muscular dystrophy failed to improve motor fu...
NPX-267 is under clinical development by NextPoint Therapeutics and currently in...
NPX-267 is under clinical development by NextPoint Therapeutics and currently in...
NPX-267 is under clinical development by NextPoint Therapeutics and currently in...
NPX-267 is under clinical development by NextPoint Therapeutics and currently in...
NPX-267 is under clinical development by NextPoint Therapeutics and currently in...
NPX-267 is under clinical development by NextPoint Therapeutics and currently in...
